- Home
- KNDI vs OBIO Comparison
KNDI vs OBIO Comparison
Compare KNDI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- OBIO
- Stock Information
- Founded
- KNDI 2002
- OBIO 2017
- Country
- KNDI China
- OBIO United States
- Employees
- KNDI N/A
- OBIO N/A
- Industry
- KNDI Auto Manufacturing
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- KNDI Consumer Discretionary
- OBIO Health Care
- Exchange
- KNDI Nasdaq
- OBIO Nasdaq
- Market Cap
- KNDI 109.2M
- OBIO 118.8M
- IPO Year
- KNDI N/A
- OBIO N/A
- Fundamental
- Price
- KNDI $1.47
- OBIO $2.73
- Analyst Decision
- KNDI
- OBIO Strong Buy
- Analyst Count
- KNDI 0
- OBIO 4
- Target Price
- KNDI N/A
- OBIO $14.67
- AVG Volume (30 Days)
- KNDI 504.6K
- OBIO 421.2K
- Earning Date
- KNDI 08-19-2025
- OBIO 08-12-2025
- Dividend Yield
- KNDI N/A
- OBIO N/A
- EPS Growth
- KNDI N/A
- OBIO N/A
- EPS
- KNDI N/A
- OBIO N/A
- Revenue
- KNDI $104,035,613.00
- OBIO $2,944,000.00
- Revenue This Year
- KNDI N/A
- OBIO $19.83
- Revenue Next Year
- KNDI N/A
- OBIO $12.53
- P/E Ratio
- KNDI N/A
- OBIO N/A
- Revenue Growth
- KNDI N/A
- OBIO 41.61
- 52 Week Low
- KNDI $0.89
- OBIO $2.37
- 52 Week High
- KNDI $2.07
- OBIO $7.04
- Technical
- Relative Strength Index (RSI)
- KNDI 61.30
- OBIO 49.28
- Support Level
- KNDI $1.40
- OBIO $2.66
- Resistance Level
- KNDI $1.77
- OBIO $3.08
- Average True Range (ATR)
- KNDI 0.12
- OBIO 0.17
- MACD
- KNDI 0.01
- OBIO 0.03
- Stochastic Oscillator
- KNDI 56.25
- OBIO 50.00
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.